Therapeutic potential and impact of nanoengineered patient‐derived mesenchymal stem cells in a murine resection and recurrence model of human glioblastoma

Documenti analoghi

• Human induced pluripotent stem cell‐derived mesenchymal stromal cells regenerate diabetic ischemic muscle
  di: Rohan Basu, et al.
  Pubblicazione: (2026)
• Reduced glutathione enhances adipose tissue‐derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway
  di: Shaoxiong Yu, et al.
  Pubblicazione: (2024)
• Correction to “Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma”
  Pubblicazione: (2024)
• Human plasma‐like medium enhances structural and metabolic maturation of human pluripotent stem cell‐derived cardiomyocytes
  di: Xiaotian Zhang, et al.
  Pubblicazione: (2025)
• Hypoxia‐preconditioned MiotEVs from bone marrow mesenchymal stem cells inhibit myocardial infarction‐induced cardiac fibrosis
  di: Jungang Nie, et al.
  Pubblicazione: (2025)